Combating COVID-19: insights by geography
Explore region-specific issues to guide your crisis response
As COVID-19’s impact spreads around the globe, leaders like you need to understand the crisis not only in your own country—but anywhere you do business. This page compiles insights from regions and countries that can help you act in this crisis with empathy and action.
There is no playbook for doing business in the time of COVID-19, but resilient, compassionate, and foresighted leadership helps. In this podcast, Deloitte US Partner Mike Kearney talks to seven Deloitte leaders from across the globe on how to lead companies, employees, and clients through a pandemic.
The COVID-19 pandemic is expected to hit consumer spending and trigger a recession in the United States. To understand how spending may evolve in a likely downturn and subsequent recovery, we analyze previous business cycles while acknowledging that this is an unprecedented situation.
How does Deloitte’s current “best case” forecast of recession to recovery compare with what the United States experienced from 2007 to 2009?
This perspective examines how the work of boards at this pivotal moment will be a critical factor in an organization’s ability to emerge from the current crisis and push forward into a new era of economic recovery and opportunity for the benefit of all stakeholders.
Deloitte US discusses certain key accounting and financial reporting considerations related to conditions that may result from the COVID-19 pandemic as well as various industry-specific considerations.
As leaders take their feet off the brakes and move forward with reentry plans, Deloitte US offers 5 considerations for establishing your next normal.
Series of articles from Deloitte China provides insight into the impact of COVID-19 on China’s consumer products and retail industries, how companies have responded, and what they can do to recover and thrive post crisis.
With the breakout of COVID-19, Deloitte China's Life Sciences & Health Care Industry team initiated a survey to understand the virus' impact on China pharmaceutical industry and measure the longer-term impact this could eventually have on their business model and operating processes.
What are some potential impacts of COVID-19 on China's health care sector? Discover six predictions in this piece from Deloitte China.
We expect that Asia-Pacific economies, led by China, are poised to begin an economic recovery sometime in the third quarter—but downside risks still remain.